Acute phosphate nephropathy

Kidney International

Volumn 76, Issue 10, 2009, Pages 1027-1034

  Markowitz, Glen S ^a   Perazella, Mark A ^b  

^a NewYork Presbyterian Hospital   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute kidney injury; Acute phosphate nephropathy; Nephrocalcinosis; Oral sodium phosphate

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM PHOSPHATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; OSMOPREP; SODIUM CHLORIDE; SODIUM DIHYDROGEN PHOSPHATE; UNCLASSIFIED DRUG; VISICOL;

ACUTE PHOSPHATE NEPHROPATHY; AGE; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COLONOSCOPY; HUMAN; HYPERTENSION; HYPOVOLEMIA; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY DISTAL TUBULE; KIDNEY INJURY; PATIENT COMPLIANCE; PHOSPHATE METABOLISM; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SHORT SURVEY; WATER ABSORPTION;

EID: 70350683546     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.308     Document Type: Short Survey

References (41)

1. Markowitz GS, Perazella MA. Drug-induced renal failure: a focus on tubulointerstitial disease. Clin Chim Acta 2005; 351: 31-47.
2. Desmeules S, Gergeron MJ, Isenring P. Acute phosphate nephropathy and renal failure. N Engl J Med 2003; 349: 1006-1007.
3. Markowitz GS, Nasr SH, Klein P et al. Renal failure and acute nephrocalcinosis following oral sodium phosphate bowel cleansing. Human Pathol 2004; 35: 675-684.
4. Murer H, Hernando N, Forster L et al. Molecular mechanisms in proximal tubular and small intestinal phosphate reabsorption. Mol Membr Biol 2001; 18: 3-11. (Pubitemid 32521591)
5. Forster IC, Hernando N, Biber J. Proximal tubular handling of phosphate: a molecular perspective. Kidney Int 2006; 70: 1548-1559.
6. Tenenhouse HS, Gauthier C, Martel J et al. Na+-phosphate cotransport in mouse distal convoluted tubule cells: evidence for Glvr-1 and Ram-1 gene expression. J Bone Miner Res 1998; 13: 590-597.
7. Sayer JA, Carr G, Simmons NL. Nephrocalcinosis: molecular insights into calcium precipitation within the kidney. Clin Sci 2004; 106: 549-561.
8. Vanner SJ, MacDonald PH, Paterson WG et al. A randomized prospective trial comparing oral sodium phosphate with standard polyethylene glycol-based lavage solution (Golytely) in the preparation of patients for colonoscopy. Am J Gastroenterol 1990; 85: 422-427.
9. Cohen SM, Wexner SD, Binderow SR et al. Prospective, randomized, endoscopic-blinded trial comparing precolonoscopy bowel cleansing methods. Dis Colon Rectum 1994; 37: 689-696.
10. Golub RW, Kerner BA, Wise WE et al. Colonoscopic bowel preparations- which one? A blinded, prospective, randomized trial. Dis Colon Rectum 1995; 38: 594-599.
11. Tan JJ, Tjandra JJ. Which is the optimal bowel preparation for colonoscopy-a meta-analysis. Colorectal Dis 2006; 8: 247-258.
12. Markowitz GS, Stokes MB, Radhakrishnan J et al. Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. J Am Soc Nephrol 2005; 16: 3389-3396.
13. Markowitz GS, Whelan J, D'Agati VD. Renal failure following bowel cleansing with a sodium phosphate purgative. Nephrol Dial Transplant 2005; 20: 850-851.
14. Gonlusen G, Akgun H, Ertan A et al. Renal failure and nephrocalcinosis associated with oral sodium phosphate bowel cleansing. Arch Patholo Lab Med 2006; 130: 101-106.
15. Manley P, Somerfield J, Simpson I et al. Bilateral uraemic optic neuritis complicating acute nephrocalcinosis. Nephrol Dial Transplant 2006; 21: 2957-2958.
16. Aasebo W, Scott H, Ganss R. Kidney biopsies taken before and after sodium phosphate bowel cleansing. Nephrol Dial Transplant 2006; 22: 920-922.
17. Beyea A, Block C, Schned A. Acute phosphate nephropathy following oral sodium phosphate solution to cleanse the bowel for colonoscopy. Am J Kidn Dis 2007; 50: 151-154.
18. Steinman TI, Samir AE, Cornell LD. Case 27-2008: a 64-year old man with abdominal pain, nausea, and an elevated level of serum creatinine. N Engl J Med 2008; 359: 951-960.
19. Connor A, Sykes L, Roberts IS et al. Acute phosphate nephropathy after sodium phosphate preparations. Br Med J 2008; 337: 47-49.
20. Ori Y, Herman M, Tobar A et al. Acute phosphate nephropathy-an emerging threat. Am J Med Sci 1008; 336: 309-314.
21. Kim HJ, Lee BH, Kwon SH et al. A case of acute phosphate nephropathy after sodium phosphate preparation. Korean J Nephrol 2008; 27: 374-377.
22. Rocuts AK, Waikar SS, Alexander MP et al. Acute phosphate nephropathy. Kidney Int 2009; 75: 987-991.
23. Demoulin N, Jadoul M, Cosyns JP et al. An easily overlooked iatrogenic cause of renal failure. Clin Nephrol 2008; 70: 176-177.
24. Slee TM, Vleming LJ, Valentijn RM. Renal failure due to acute phosphate nephropathy. Netherlands J Med 2008; 66: 438-441.
25. Asplin JR, Mandel NS, Coe FL. Evidence of calcium phosphate supersaturation in the loop of Henle. Am J Physiol 1996; 270: F604-F613.
26. Verhulst A, Asselman M, De Naeyer S et al. Preconditioning of the distal tubular epithelium of the human kidney precedes nephrocalcinosis. Kidney Int 2005; 68: 1643-1647.
27. Hurst FP, Bohen EM, Osgard EM et al. Acute kidney injury associated with oral sodium phosphate purgative use: an observational retrospective cohort study. J Am Soc Nephrol 2007; 18: 3192-3198.
28. Brunelli SM, Lewis JD, Gupta M et al. Risk of kidney injury following use of oral phosphosoda bowel preparations. J Am Soc Nephrol 2007; 18: 3199-3205.
29. Russmann S, Lamerato L, Marfatia A et al. Risk of impaired renal function after colonoscopy: a cohort study in patients receiving either oral sodium phosphate or polyethylene glycol. Am J Gastroenterol 2007; 102: 2655-2663.
30. Russmann S, Lamerato L, Motsko SP et al. Risk of further decline in renal function after the use of oral sodium phosphate or polyethylene glycol in patients with a preexisting glomerular filtration rate below 60ml/min. Am J Gastroenterol 2008; 103: 2707-2716.
31. Khurana A, McLean L, Atkinson S et al. The effect of oral sodium phosphate drug products on renal function in adults undergoing bowel endoscopy. Arch Intern Med 2008; 168: 593-597.
32. Singal AK, Rosman AS, Post JB et al. The renal safety of bowel preparations for colonoscopy: a comparative study of oralsodium phosphate solution and polyethylene glycol. Aliment Pharmacol Ther 2008; 27: 41-47.
33. Johanson JF, Popp JW, Cohen LB et al. A randomized, multicenter study comparing the safety and efficacy of sodium phosphate tablets with 2L polyethylene glycol solution plus bisacodyl tablets for colon cleansing. Am J Gastroenterol 2007; 102: 2238-2246.
34. Brunelli SM. Association between oral sodium phosphate bowel preparations and kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 53: 448-456.
35. Abaskharoun R, Depew W, Vanner S. Changes in renal function following administration of oral sodium phosphate or polyethylene glycol for colon cleansing before colonoscopy. Can J Gastroenterol 2007; 21: 227-231.
36. Ainley EJ, Winwood PJ, Begley JP. Measurement of serum electrolytes and phosphate after sodium phosphate colonoscopy bowel preparation. Digestive Dis and Sci 2005; 50: 1319-1323.
37. Gumurdulu Y, Serin E, Ozer B et al. Age as a predictor of hyperphosphatemia after oral phosphosoda administration for colon preparation. J Gastroenterol Hepatol 2004; 19: 68-72.
38. Haithcock D, Jiao H, Cui XL et al. Renal proximal tubular AT2 receptor: Signaling and transport. J Am Soc Nephrol 1999; 10: S69-S74.
39. Hesse A, Heimbach D. Causes of phosphate stone formation and the importance of metaphylaxis by urinary acidification: a review. World J Urol 1999; 17: 308-315.
40. Geary CP, Cousins FB. An oestrogen-linked nephrocalcinosis in rats. Br J Exp Pathol 1969; 50: 507-515
41. Ehrenpreis ED. Increased serum phosphate levels and calcium fluxes are seen in smaller individuals after a single dose of sodium phosphate bowel cleansing solution: a pharmacologic analysis. Aliment Pharmacol Ther 2009; E-pub ahead of print.